Australia's largest stock trading and investment forum Australia's #1 stock forum

BOD

Click for more information

0.00%

2.4¢ bod science limited

News: BDA BOD Australia secures binding letter of intent with a Swiss manufacturer, page-163

First 163 Last

Share
Profile

Follow
Matt Adl

1,196 Posts.

07/04/17

16:30

Post #: 23941803
Share

Originally posted by jeans_sammy ↑

Bod has two different market opportunities within same segments.

1# Achieving a growth in existing beauty and skin care business
2# Maximize opportunities with swiss base Linnea for MM Products to include a unique medicinal skin care range plus a therapeutic product(s) in areas such as but not limited to nausea and vomiting, anti-inflammation, neuroprotection and anxiety disorders

However, implementing right strategy and achieving actual growth could take some time. But that's the reason BOD is actually trading less than $10m EV.

If BOD could increase revenue with existing business in coming months and get regulatory approval to Import and start clinical trails on future products produced by Linnea; then MC over $40-60m could be well achieved in coming months (in line with peers such as CPH, AC8 & MMJ). However, one step at a time and believe BOD management is slowly moving to the right direction.

cheers
J

Expand

Next few weeks marks new distribution agreement on current and future products I believe, that should bring in some further revenues.

BDA Price at posting: 30.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

PRU

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

As Nvidia cools, we're looking to Aussie AI

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

CBA breaks trading record on strong day for Aussie financials

OCC

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

LAM

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

QML

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

There are more pages in this discussion • 4 more messages in this thread...

First 163 Last

Add BOD (ASX) to my watchlist